Physician profile
Brian Au
NPI 1508392572
$10,749.38
in general payments reported to CMS, 2019-2025
18 companies · $668 in 2025
The $668 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,986 · 2022: $1,533 · 2023: $2,602 · 2024: $961 · 2025: $668.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,230.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,944.62 | 2021-2025 | Prostep Mica, Hoffmann, Valor |
| Arthrex, INC. | $3,117.77 | 2021 | |
| Biotissue Holdings INC. | $777.89 | 2021-2023 | |
| Smith+Nephew, INC. | $503.33 | 2021-2023 | Renasys Go V2 Home |
| Paragon 28, INC. | $467.02 | 2022-2023 | Portfolio, Additive Orthopedics |
| Linvatec Corporation | $400.07 | 2023-2024 | Biobrace 23mm, Colink Plating System, Fracture and Correction Colag 2 |
| Integra Lifesciences Corporation | $377.77 | 2021-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| In2bones USA, LLC | $345.10 | 2022 | |
| Ossio INC | $203.78 | 2021 | |
| Acera Surgical, INC. | $181.66 | 2021-2023 | Restrata Wound Matrix |
| Averitas Pharma INC. | $120.05 | 2023 | Qutenza |
| Amdt Holdings, INC. | $80.06 | 2021 | |
| Conmed Corporation | $56.46 | 2023 | 5ms |
| Depuy Synthes Sales INC. | $45.32 | 2025 | Minibunion |
| Saxum Surgical, INC. | $43.87 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $31.97 | 2021 | |
| Krystal Biotech INC | $29.93 | 2023 | Vyjuvek |
| Bard Peripheral Vascular, INC. | $22.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Au listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.